Branch Retinal Vein Occlusion

Retina: Fourth Edition

Volumn 2-3, Issue , 2005, Pages 1349-1354

  Phillips, Stephen ^a   Fekrat, Sharon ^b   Finkelstein, Daniel ^c  

^a Carolina Centers for Sight   (United States)

^b DUKE UNIVERSITY EYE CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84917132554     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-02598-0.50077-X     Document Type: Chapter

References (46)

1. Branch Vein Occlusion Study Group Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. Arch Ophthalmol 1986, 104:34-41.
2. Zhao J, Sastry SM, Sperduto RD, et al. Arteriovenous crossing patterns in branch retinal vein occlusion: The Eye Disease Case-Control Study Group. Ophthalmology 1993, 100:423-428.
3. Eye Disease Case-Control Study Group Risk factors for branch retinal vein occlusion. Am J Ophthalmol 1993, 116:286-296.
4. Lahey JM, Tunc M, Kearney J, et al. Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age. Ophthalmology 2002, 109:126-131.
5. Lahey JM, Kearney JJ, Tunc M Hypercoagulable states and central retinal vein occlusion. Curr Opin Pulm Med 2003, 9:385-392.
6. 12, and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol 2003, 136:1136-1150.
7. Ariturk N, Oge Y, Erkan D, et al. Relation between retinal vein occlusions and axial length. Br J Ophthalmol 1996, 80:633-636.
8. Majji AB, Janarthanan M, Naduvilath TJ Significance of refractive status in branch retinal vein occlusion: a case-control study. Retina 1997, 17:200-204.
9. Simons BD, Brucker AJ Branch retinal vein occlusion: axial length and other risk factors. Retina 1997, 17:191-195.
10. Timmerman EA, de Lavalette VW, van den Brom HJ Axial length as a risk factor to branch retinal vein occlusion. Retina 1997, 17:196-199.
11. Weinberg D, Dodwell DG, Fern SA Anatomy of arteriovenous crossings in branch retinal vein occlusion. Am J Ophthalmol 1990, 109:298-302.
12. Duker JS, Brown GC Anterior location of the crossing artery in branch retinal vein occlusion. Arch Ophthalmol 1989, 107:998-1000.
13. Seitz R The retinal vessels 1964, 20-74. CV Mosby, St Louis.
14. Frangieh GT, Green WR, Barraquer-Somers E Histopathological study of nine branch retinal vein occlusions. Arch Ophthalmol 1982, 100:1132-1140.
15. Bandello F, Tavola A, Pierro L, et al. Axial length and refraction in retinal vein occlusions. Ophthalmologica 1998, 212:133-135.
16. Majii AB, Janarthnan M, Naduvilath TJ Significance of refractive status in branch retinal vein occlusion: a case-control study. Retina 1997, 17:200-204.
17. Kumar B, Yu DY, Morgan WH, et al. The distribution of angioarchitectural changes within the vicinity of the arteriovenous crossing in branch retinal vein occlusion. Ophthalmology 1998, 105:424-427.
18. Clemett RS Retinal branch vein occlusion: changes at the site of obstruction. Br J Ophthalmol 1974, 58:548-554.
19. Bowers DK, Finkelstein D, Wolff SM, et al. Branch retinal vein occlusion: a clinicopathological case report. Retina 1987, 7:252-259.
20. Christoffersen NLB, Larsen M Pathophysiology and hemodynamics of branch retinal vein occlusion. Ophthalmology 1999, 106:2054-2062.
21. Finkelstein D, Clarkson JG and The Branch Vein Occlusion Study Group. Branch and central retinal vein occlusions. Focal points 1987: Clinical modules for ophthalmologists 5 (module 12), no 3. American Academy of Ophthalmology.
22. Gutman FA, Zegarra H Macular edema secondary to occlusion of the retinal veins. Surv Ophthalmol 1984, 28:462-470.
23. Hayreh SS, Rojas P, Podhajsky P, et al. Ocular neovascularization with retinal vascular occlusion. III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology 1983, 90:488-506.
24. Joffe L, Goldberg RE, Magargal LE, et al. Macular branch vein occlusion. Ophthalmology 1980, 87:91-98.
25. Finkelstein D Ischemic macular edema: recognition and favorable natural history in branch vein occlusion. Arch Ophthalmol 1992, 110:1427-1434.
26. Branch Vein Occlusion Study Group Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984, 98:271-282.
27. Wilson DJ, Finkelstein D, Quigley HA, et al. Macular grid photocoagulation: an experimental study on the primate retina. Arch Ophthalmol 1988, 106:100-105.
28. Kumar B, Yu DY, Morgan WH, et al. The distribution of angioarchitectural changes within the vicinity of the arteriovenous crossing in branch retinal vein occlusion. Ophthalmology 1998, 105:424-427.
29. Osterloh MD, Charles S Surgical decompression of branch retinal vein occlusions. Arch Ophthalmol 1988, 106:1469-1471.
30. Opremcak EM, Bruce RA Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: a prospective review of 15 cases. Retina 1999, 19:1-5.
31. Mester U, Dillinger P Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion. Retina 2002, 22:740-746.
32. Cahill MT, Kaiser PK, Sears JE, et al. The effect of arteriovenous sheathotomy on cystoid macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol 2003, 87:1329-1332.
33. Han DP, Bennett SR, Williams DF, et al. Arteriovenous crossing dissection without separation of the retina vessels for treatment of branch retinal vein occlusion. Retina 2003, 23:145-151.
34. Cahill MT, Fekrat S Arteriovenous sheathotomy for branch retinal vein occlusion. Ophthalmol Clin N Am 2002, 15:417-423.
35. Takahashi M, Hikichi T, Akiba J, et al. Role of the vitreous and macular edema in branch retinal vein occlusion. Ophthalmic Surg Lasers 1997, 28:294-299.
36. Kurimoto M, Takagi H, Suzuma K, et al. Vitrectomy for macular edema secondary to retinal vein occlusion: evaluation by retinal thickness analyzer. Jpn J Clin Ophthalmol 1999, 53:717-720.
37. Saika S, Tanaka T, Miyamoto T, et al. Surgical posterior vitreous detachment combined with gas/air tamponade for treating macular edema associated with branch retinal vein occlusion: retinal tomography and visual outcome. Graefes Arch Clin Exp Ophthalmol 2001, 239:729-732.
38. Wilson CA, Berkowitz BA, Sato Y, et al. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 1992, 110:1155-1159.
39. McCuen BW, Bessler M, Tano Y, et al. The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol 1981, 91:785-788.
40. Hida T, Chandler D, Arena J, et al. Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol 1986, 101:190-195.
41. Schindler R, Chandler D, Thresher R, et al. The clearance of intravitreal triamcinolone acetonide. Am J Ophthalmol 1982, 93:415-417.
42. Beer PM, Bakri SJ, Singh RJ, et al. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003, 110:681-686.
43. Martidis A, Duker JS, Greenberg P, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002, 109:920-927.
44. Park CH, Jaffe GJ, Fekrat S Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 2003, 136:419-425.
45. Greenberg PB, Martidis A, Rogers AH, et al. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002, 86:247-248.
46. Ip MS, Kumar KS Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion. Arch Ophthalmol 2002, 120:1217-1219.